| AUS | Artificial urinary sphincter |
| AUA | American Urological Association |
| BMI | Body mass index |
| CUA | Canadian Urological Association |
| EAU | European Association of Urology |
| ExMI | Extracorporeal magnetic innervation |
| FDA | Food and Drug Administration |
| GSM | Genitourinary syndrome of menopause |
| ICS | International Continence Society |
| ICIQ-SF | International Consultation on Incontinence Questionnaire—Short Form |
| ISD | Intrinsic sphincter deficiency |
| LUTS | Lower urinary tract symptoms |
| MeSH | Medical Subject Headings |
| MUS | Mid-urethral sling |
| NICE | National Institute for Health and Care Excellence |
| OAB | Overactive bladder |
| PFMT | Pelvic floor muscle training |
| PTNS | Posterior tibial nerve stimulation |
| QoL | Quality of life |
| RCT | Randomized controlled trial |
| RF | Radiofrequency |
| SNM | Sacral neuromodulation |
| SNRIs | Serotonin and norepinephrine reuptake inhibitors |
| SUI | Stress urinary incontinence |
| TAS-303 | Selective norepinephrine reuptake inhibitor TAS-303 |
| TENS | Transcutaneous electrical nerve stimulation |
| TTNS | Transcutaneous tibial nerve stimulation |
| UUI | Urgency urinary incontinence |
| UI | Urinary incontinence |
| US | United States (in context of FDA approval) |